The Sanger Institute and Astra Zeneca organised the inaugural Sanger Institute-AstraZeneca conference centred on the application of CRISPR technology to the understanding and treatment of human disease.
The meeting took place on 18-19 January 2016 at the Wellcome Genome Campus Conference Centre, Cambridge UK.
The goal of Creating a CRISPR Community is to foster networking and collaborations between scientists from academia and the pharmaceutical and biotechnology industries who are applying CRISPR systems to the study of human disease and its treatment. The meeting brought together experts from Europe, China, Japan, Australasia and the US to discuss topics such as:
- the therapeutic applications of CRISPR
- advances in genome editing technology
- challenges to progressing disease models
- CRISPR-based genome-wide screening
- DNA repair
- the biosafety of gene editing